Fig. 1From: Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort studyComparison of cumulative incidence for cardiocerebrovascular disease (CVD) outcomes according to the baseline CVD. a Incidence of total composite cardiovascular events. b Incidence of hospitalization for heart failureBack to article page